CARE Lab

Publications

71 peer-reviewed publications. This list is updated quarterly; for the most current record and citation metrics, see Google Scholar.

Peer-reviewed papers

71

First author

25

Corresponding author

11

Citation metrics on Google Scholar ↗ ORCID ↗

Last updated September 2026

Publications per year

2019 2020 2021 2022 2023 2024 2025 2026

2026 (13)

  1. Yuen ASC, Chen B, Chan AYL, Hong B, Kim JH, Hayes JF, Osborn DPJ, Besag FMC, Howard R, Wilson MG, Lau WCY, Wong ICK, Wei L, Shin JY, Man KKC. Risk of fracture with gabapentinoid treatment in older adults: a multinational population-based study. The Lancet Healthy Longevity. 7(6):100868
  2. Lim H, Kim JH, Ye BD, Hong B, Suh B, Lee JE, Zhang Y, Qiu H, Nakajo K, Shin JY. Real-world patterns of inflammatory bowel disease treatment across adult and pediatric populations: a nationwide cohort study in South Korea. Frontiers in Medicine. 13:1883050First author
  3. Park J, Kim JH, Kim YS, Lim G, Song HJ, Rhee SY, Hwang S, Cho D, Kim M, Kim BY, Jeong CW, Kim DY, Park HA, Kim MH, Kim SH, Seo WW, Kim WJ, Suh YS, Park RW, Shin JY. GLP-1 Receptor Agonists for Weight Loss and Risk of Major Safety Outcomes: A Multicentre Cohort Study. Diabetes, Obesity and Metabolism. 28(9):8649-8659First author
  4. Jeon M, Lee Y, Woo J, Kim JH, Shin JY. Effect of anemia developed after ruxolitinib initiation on adverse outcomes in patients with myelofibrosis: a nationwide cohort study. Blood Cancer Journal. 16(1):108Corresponding
  5. Jung K, Kim GA, Woo J, Youn J, Choi EY, Bea S, Choi A, Kim JH, Jang H, Lee DH, Joo SK, Shin JY, Kim W. Ursodeoxycholic acid and long COVID in steatotic liver disease: a nationwide cohort study. Clinical and Molecular Hepatology. 32(3):1364-1378
  6. Ko HY, Shin JY, Jung K, Bea S, Hong B, Noh Y, Bae JH, Kwak SH, Cho YM, Lim GY, Ahn J, Ryu S, Kim JH, Chang Y. Timing of Antidiabetic Medication Initiation and Risk of Cardiovascular Events and Mortality. JAMA Network Open. 9(6):e2619362Corresponding
  7. Jung K, Kim JH, Lim H, Kim S, Hyun BJ, Yoo SH, Shin JY, Kim SJ. Comparative Effectiveness of Tafasitamab Plus Lenalidomide versus Ifosfamide, Carboplatin, Etoposide-Based Chemotherapy for Relapsed/Refractory Diffuse Large B-cell Lymphoma: An External Control Arm Study. Cancer Research and Treatment. Epub ahead of printFirst author
  8. Suh B, Oh HS, Shin JY, Kim JH. Regional Trends in the Opioid Epidemic Using Safety Signals of Drug Abuse and Dependence: A Disproportionality Analysis Using VigiBase. Drugs-Real World Outcomes. 13(2):201-210Corresponding
  9. Kim S, Kim JH, Shin JY, Kim U, Hong B, Kim WJ, Choi H, Lee H. Risk of major bleeding events associated with concomitant use of selective serotonin reuptake inhibitors and anti-thrombotic drugs: a nationwide case-case-time-control study. Age and Ageing. 55(5):afag105First author
  10. Lim G, Shin JY, Hyeon DE, Kim JH, Kim Y, Kim HS, Yoo WH, Song BJ, Jeong CW, Park HA, Cha JM, Kim JH, Jung J, Moon KM, Rhee SY, Kwag SJ, Yu SN, Lee S, Park S, Park RW, Kim JH. Comparative safety of Potassium-competitive acid blockers on the risk of clostridium difficile infection: a multicenter cohort study. American Journal of Gastroenterology. Epub ahead of printCorresponding
  11. Jung K, Kim JH, Hyeon DE, Ji J, Lee MY, Choi H, Lee DY, Kim MW, Jang Y, Hwang S, Cho J, Song SY, Rhee SY, Cha JM, Seo WW, Jeong CW, Kwag SJ, Kim WJ, Hwang J, Kim MH, Park RW, Shin JY. Antidepressants and the risk of hyponatremia: A multi-institutional cohort study using observational medical outcomes partnership-Common Data Model. British Journal of Clinical Pharmacology. 92(6):1706-1715First author
  12. Jeon M, Hong B, Ko HY, Song HJ, Kwak SH, Kim JH, Shin JY. Glucagon-like peptide-1 receptor agonists and risk of osteoarthritis among individuals with type 2 diabetes: A population-based cohort study. Diabetes Research and Clinical Practice. 232:113091Corresponding
  13. Jung K, Shin JY, Kim JH. Reply to 'Sacubitril/valsartan in heart failure: a critical look at dementia risk and future study pathways'. European Heart Journal - Cardiovascular Pharmacotherapy. 12(1):54-55Corresponding

2025 (17)

  1. Woo J, Kim SW, Kim JH, Yuk J, Jung K, Cho Y, Park Y, Shin JY, Shin HY. Identification of High-Risk Population for Mortality and Severe Clinical Outcomes Among Patients With Myasthenia Gravis: A Nationwide Population-Based Cohort Study in Korea. Journal of Korean Medical Science. 40(37):e240
  2. Seo HJ, Kim JH, Yoon SE, Kim WS, Yon DK, Shin JY, Kim SJ. Effectiveness of CAR-T Cell Therapies for Relapsed/Refractory Follicular Lymphoma: An External Control Arm Study. Cancer Research and Treatment. Epub ahead of printFirst author
  3. Kim JH, Bea S, Choi Y, Yoon SE, Kim WS, Kim SJ, Shin JY. Effectiveness of axicabtagene ciloleucel versus conventional treatments as first-line therapy for high-risk large B-cell lymphoma: an external comparator study. BMC Cancer. 25(1):1681First author
  4. Jung K, Byun SJ, Lim G, Lee JE, Lee H, Kim JH, Shin JY. Potential Bias in Self-Controlled Case Series Design: Impact of Incident Versus Prevalent Scenarios of Exposure and Outcome. Pharmacoepidemiology and Drug Safety. 34(10):e70234Corresponding
  5. Byun JY, Kim J, Park S, Sun JM, Lee SH, Ahn JS, Ahn MJ, Kim JH, Lee EK, Jung HA. A matching-adjusted indirect comparison of first-line lorlatinib and alectinib for the treatment of ALK-rearranged advanced non-small cell lung cancer. European Journal of Cancer. 230:115805
  6. Chan AYL, Bahmanyar S, Beyene K, ... Kim JH, ... Shin JY, ... Wong ICK. International Trends in Opioid Prescribing by Age and Sex from 2001 to 2019: An Observational Study Using Population-Based Databases from 18 Countries and One Special Administrative Region. CNS Drugs. 39(11):1173-1185
  7. Luo H, Koponen M, ... Kim JH, ... Shin JY, ... Wong ICK. A multinational cohort study of trends in survival following dementia diagnosis. Communications Medicine. 5(1):203
  8. Ko HY, Yoon D, Kim JH, Jeong HE, Hong SB, Shin WC, Shin JY; CoVaSC Investigators. Risk of new-onset seizures following immunization against COVID-19: a self-controlled case-series study. Epidemiology and Health. 47:e2025024
  9. Lee H, Yoon D, Kim JH, Noh Y, Joo EJ, Han JY, Choe YJ, Shin JY. Association of Influenza Vaccination During Pregnancy with Health Outcomes in Mothers and Children: A Population-Based Cohort Study. Clinical Pharmacology and Therapeutics. 117(5):1381-1392
  10. Seo HJ, Yoo WH, Jung K, Kim JW, Shin JY, Kim JH, Kim WS. Comparative Effectiveness of Anbalcabtagene Autoleucel versus Tisagenlecleucel in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma. Cancer Research and Treatment. 58(3):945-953Corresponding
  11. Kim S, Ko HY, Oh J, Yoon D, Kim JH, Choe YJ, Shin JY; CoVaSC Investigators. Risk of Kawasaki Disease/Multisystem Inflammatory Syndrome Following COVID-19 Vaccination in Korean Children: A Self-Controlled Case Series Study. Journal of Korean Medical Science. 40(3):e10
  12. Cho Y, Park S, Jung K, Lee JE, Woo J, Kim JH, Shin JY. Effect of Biological Therapy for Psoriasis on the Development of Psoriatic Arthritis: A Population-Based Cohort Study. BioDrugs. 39(1):143-152
  13. Cho Y, Choi EY, Choi A, Han JY, Ye BD, Kim JH, Shin JY. Anti-Tumor Necrosis Factor Therapy and the Risk of Gestational Diabetes in Pregnant Women With Inflammatory Bowel Disease. American Journal of Gastroenterology. 120(1):241-250Corresponding
  14. Kim JH, Choi A, Bae G, Joo EJ, Choi MJ, Huh K, Lee H, Kim J, Kim DH, Yoo MG, Jo IU, Lee PH, Lee GW, Jung HS, Jung J, Shin JY. Selected Acute Safety Events Following the Use of Nirmatrelvir/Ritonavir or Molnupiravir for COVID-19: A Nationwide Cohort Study in South Korea. Clinical Pharmacology and Therapeutics. 117(2):445-453First author
  15. Jung K, Kim JH, Bea S, Ko HY, You SC, Choi EK, Lee S, Lim M, Kim GJ, Kang DY, Shin JY. Association between sacubitril/valsartan and risk of dementia in patients with heart failure: a nationwide cohort study. European Heart Journal - Cardiovascular Pharmacotherapy. 11(5):412-421First author
  16. Woo J, Kim MK, Lim H, Kim JH, Jung H, Kim HA, Shin JY; CoVaSC Investigators. Risk of new-onset polymyalgia rheumatica following COVID-19 vaccination in South Korea: a self-controlled case-series study. RMD Open. 11(2):e005138
  17. Cho Y, Yoon D, Khosrow-Khavar F, Song M, Kang EH, Kim JH, Shin JY. Cardiovascular, cancer, and infection risks of Janus kinase inhibitors in rheumatoid arthritis and ulcerative colitis: A nationwide cohort study. Journal of Internal Medicine. 297(4):366-381Corresponding

2024 (11)

  1. Jung H, Park JY, Yoon D, Kang DY, Jung J, Kim JH, Shin JY. Patient-Reported Adverse Events Among Elderly Patients Receiving Novel Oral COVID-19 Antivirals: A Nationwide Sampled Survey in Korea. Journal of Korean Medical Science. 39(41):e270Corresponding
  2. Yoon D, Jung K, Kim JH, Ko HY, Yoon BA, Shin JY. Risk for Facial Palsy after COVID-19 Vaccination, South Korea, 2021-2022. Emerging Infectious Diseases. 30(11):2313-2322
  3. Kim JH, Yoon D, Ko HY, Jung K, Sunwoo JS, Shin WC, Byun JI, Shin JY. Risk of encephalitis and meningitis after COVID-19 vaccination in South Korea: a self-controlled case series analysis. BMC Medicine. 22(1):123First author
  4. Kim DH, Kim JH, Oh IS, Choe YJ, Choe SA, Shin JY. Adverse Events Following COVID-19 Vaccination in Adolescents: Insights From Pharmacovigilance Study of VigiBase. Journal of Korean Medical Science. 39(8):e76First author
  5. Yoon D, Kim JH, Jeong HE, Ko HY, Kim SR, Shin JY; CoVaSC Investigators. Risk of anaphylaxis after COVID-19 vaccination in South Korea: A nationwide self-controlled case series analysis. Allergy. 79(3):754-757First author
  6. Jung J, Kim JH, Bae JH, Woo SS, Lee H, Shin JY. A real-world pharmacovigilance study on cardiovascular adverse events of tisagenlecleucel using machine learning approach. Scientific Reports. 14(1):13641First author
  7. Oh IS, Kim JH, Huh K, Jang SH, Shin JY. Impact of National Public-Private Mix and Medical Expense Support Program to Control Tuberculosis in South Korea: An Interrupted Time Series Analysis. Journal of Infectious Diseases. 229(6):1878-1882
  8. Yoon D, Jeon HL, Kim JH, Lee H, Shin JY. Cardiovascular, Neurological, and Immunological Adverse Events and the 23-Valent Pneumococcal Polysaccharide Vaccine. JAMA Network Open. 7(1):e2352597
  9. Kim JH, Shen CY, Au PC, Baek YH, Cheung CL, Chung WP, Kleinman NJ, Lam TC, Liao TC, Lin TC, Shin JY, Sing CW, Wong ICK, Lai EC. Bone-targeting agents in major solid tumour metastases: a multinational cohort study. BMJ Supportive & Palliative Care. 13(e3):e1064-e1073First author
  10. Kim JH, Yoon D, Lee H, Choe YJ, Shin JY. Neurological and immunological adverse events after pneumococcal conjugate vaccine in children using national immunization programme registry data. International Journal of Epidemiology. 53(1):dyae010First author
  11. Lee H, Bea S, Kim JH, Jeong HE, Jang SH, Son H, Shin JY. Predictors, mortality, and health outcomes of intensive phase non-adherence to a regimen in patients with drug-susceptible tuberculosis: a nationwide linkage database. Public Health. 229:167-175

2023 (10)

  1. Kim JH, Yoon D, Noh Y, Jung J, Choe YJ, Shin JY. Predictors of COVID-19 Vaccine Hesitancy Among Parents of Children Aged 5-11 Years in Korea. Journal of Korean Medical Science. 38(42):e315First author
  2. Noh Y, Ko HY, Kim JH, Yoon D, Choe YJ, Choe SA, Jung J, Shin JY. Barriers to COVID-19 vaccine surveillance: the issue of under-reporting adverse events. Epidemiology and Health. 45:e2023054
  3. Lee H, Baek YH, Kim JH, Liao TC, Lau WCY, Man KKC, Qin X, Wood S, Ilomäki J, Bell JS, Lai EC, Leung MTY, Chan AYL, Chui CSL, Wong ICK, Shin JY. Trends of polypharmacy among older people in Asia, Australia and the United Kingdom: a multinational population-based study. Age and Ageing. 52(2):afad014
  4. Kim H, Shin JY, Chen J, Kim JH, Noh Y, Cheong HJ, Oh YM, Guignard A, Shantakumar S. Risk Factors of Pertussis Among Older Adults in South Korea: A Nationwide Health Data-Based Case-Control Study. Infectious Diseases and Therapy. 12(2):545-561
  5. Tsai DH, Bell JS, ... Kim JH, ... Shin JY, ... Wong ICK, Lai EC. Cross-Regional Data Initiative for the Assessment and Development of Treatment for Neurological and Mental Disorders. Clinical Epidemiology. 15:1241-1252
  6. Chen J, Shin JY, Kim H, Kim JH, Choi A, Cheong HJ, Oh YM, Guignard A, Shantakumar S. Incidence and Healthcare Burden of Pertussis among Older Adults with and without Pre-Existing Chronic Obstructive Pulmonary Disease or Asthma in South Korea. Chronic Obstructive Pulmonary Diseases. 20(1):126-134
  7. Park S, Kim JH, Kim S, Kang J, Moon S, Kim SJ, Shin JY. Comparison of tisagenlecleucel with conventional treatments for relapsed/refractory diffuse large B-cell lymphomas: a retrospective external comparator study. Blood Cancer Journal. 13(1):123First author
  8. Kim JH, Lee H, Oh IS, Jeong HE, Bea S, Jang SH, Son H, Shin JY. Comparative safety of bedaquiline and delamanid in patients with multidrug resistant tuberculosis: A nationwide retrospective cohort study. Journal of Microbiology, Immunology and Infection. 56(4):842-852First author
  9. Bea S, Oh IS, Kim JH, Sinn DH, Chang Y, Ryu S, Shin JY. High-Intensity Statin Reduces the Risk of Mortality Among Chronic Liver Disease Patients With Atherosclerotic Cardiovascular Disease: A Population-Based Cohort Study. Journal of the American Heart Association. 12(8):e028310
  10. Jeong HE, Bea S, Kim JH, Jang SH, Son H, Shin JY. Socioeconomic disparities and multidrug-resistant tuberculosis in South Korea: Focus on immigrants and income levels. Journal of Microbiology, Immunology and Infection. 56(2):424-428

2022 (7)

  1. Lee JE, Kim JH, Bae JH, Song I, Shin JY. Detecting early safety signals of infliximab using machine learning algorithms in the Korea adverse event reporting system. Scientific Reports. 12(1):14869First author
  2. Lee H, Hong B, Kim S, Kim JH, Choi NK, Jung SY, Shin JY. Post-marketing surveillance study on influenza vaccine in South Korea using a nationwide spontaneous reporting database with multiple data mining methods. Scientific Reports. 12(1):20256
  3. Shen CY, Au PC, Baek YH, Cheung CL, Chung WP, Kim JH, Kleinman NJ, Lam TC, Liao TC, Lin TC, Shin JY, Sing CW, Wong ICK, Lai EC. Comparative Treatment Persistence with Bone-Targeting Agents Among Asian Patients with Bone Metastases from Solid Tumors: A Multinational Retrospective Cohort Study. BioDrugs. 36(3):381-392
  4. Park S, Lee H, Kim JH, Jeon HL, Shin JY. Association between tramadol use and seizures: A nationwide case-case-time-control study. Pharmacoepidemiology and Drug Safety. 31(6):614-622
  5. Noh Y, Kim JH, Yoon D, Choe YJ, Choe SA, Jung J, Lee SW, Shin JY. Predictors of COVID-19 booster vaccine hesitancy among fully vaccinated adults in Korea: a nationwide cross-sectional survey. Epidemiology and Health. 44:e2022061First author
  6. Kim JH, Jeong HE, Baek YH, Cho SW, Lim H, Shin JY. Treatment pattern in postmenopausal women with osteoporosis: a population-based cohort study in South Korea. Journal of Bone and Mineral Metabolism. 40(1):109-119First author
  7. Baek YH, Kang EJ, Hong S, Park S, Kim JH, Shin JY. Survival outcomes of patients with nonsmall cell lung cancer concomitantly receiving proton pump inhibitors and immune checkpoint inhibitors. International Journal of Cancer. 150(8):1291-1300

2021 (5)

  1. Bea S, Lee H, Kim JH, Jang SH, Son H, Kwon JW, Shin JY. Adherence and Associated Factors of Treatment Regimen in Drug-Susceptible Tuberculosis Patients. Frontiers in Pharmacology. 12:625078
  2. Yoon D, Kim J, Shin J. Differential Demographic and Clinical Characteristics between MMR Vaccinated and Unvaccinated Children in South Korea: A Nationwide Study. Vaccines. 9(6):653First author
  3. Baek YH, Cho SW, Jeong HE, Kim JH, Hwang Y, Lange JL, Shin JY. 10-Year Fracture Risk in Postmenopausal Women with Osteopenia and Osteoporosis in South Korea. Endocrinology and Metabolism. 36(6):1178-1188
  4. Park HH, Kim JH, Yoon D, Lee H, Shin JY. Gender differences in the adverse events associated with cardiovascular drugs in a spontaneous reporting system in South Korea. International Journal of Clinical Pharmacy. 43(4):1036-1044
  5. Choe YJ, Lee H, Kim JH, Choi WS, Shin JY. Anaphylaxis following vaccination among children in Asia: A large-linked database study. Allergy. 76(4):1246-1249

2020 (6)

  1. Ilomäki J, Bell JS, ... Kim JH, ... Shin JY, ... Wong ICK. Application of Healthcare 'Big Data' in CNS Drug Research: The Example of the Neurological and mental health Global Epidemiology Network (NeuroGEN). CNS Drugs. 34(9):897-913
  2. Lee H, Kim JH, Choe YJ, Shin JY. Safety Surveillance of Pneumococcal Vaccine Using Three Algorithms: Disproportionality Methods, Empirical Bayes Geometric Mean, and Tree-Based Scan Statistic. Vaccines. 8(2):242
  3. Kim JH, Byun SJ, Shin JY. Authors' Response to Association between Acetylcholinesterase Inhibitors and Osteoporotic Fractures in Older Persons With Alzheimer's Disease. Journal of the American Medical Directors Association. 21(5):707First author
  4. Kim JH, Lee H, Shin JY. Bacillus Calmette-Guérin (BCG) vaccine safety surveillance in the Korea Adverse Event Reporting System using the tree-based scan statistic and conventional disproportionality-based algorithms. Vaccine. 38(21):3702-3710First author
  5. Yoon D, Kim JH, Lee H, Shin JY. Updates on Vaccine Safety and Post-Licensure Surveillance for Adverse Events Following Immunization in South Korea, 2005-2017. Yonsei Medical Journal. 61(7):623-630
  6. Kim JH, Baek YH, Lee H, Choe YJ, Shin HJ, Shin JY. Clinical outcomes of COVID-19 following the use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers among patients with hypertension in Korea: a nationwide study. Epidemiology and Health. 43:e2021004First author

2019 (2)

  1. Shin JY, Shin E, Jeong HE, Kim JH, Lee EK. Current status of pharmacovigilance regulatory structures, processes, and outcomes in the Asia-Pacific region: Survey results from 15 countries. Pharmacoepidemiology and Drug Safety. 28(3):362-369
  2. Kang HR, Kim JH, Lee EK, Shin JY. Risk of neuropsychiatric adverse events associated with the use of oseltamivir: a nationwide population-based case-crossover study-authors' response. Journal of Antimicrobial Chemotherapy. 74(6):1764-1765